These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35378561)

  • 1. The Negative Association Between NAFLD Severity and CKD in a Non-Diabetic Gouty Population.
    Huang Y; Zhou Y; Wang Y; Chi J; Lv W; Wang Y; Chen Y
    Horm Metab Res; 2022 May; 54(5):325-334. PubMed ID: 35378561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.
    Bellinato F; Goio I; Malara G; Rosato A; Targher G; Girolomoni G; Gisondi P
    J Cutan Med Surg; 2022; 26(3):249-255. PubMed ID: 34894782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of nonalcoholic fatty liver disease in gout patients with frequent flares: a retrospective cohort study.
    Si K; Chi J; Xu L; Dong B; Liu C; Chen Y; Wang Y
    Clin Rheumatol; 2023 May; 42(5):1389-1395. PubMed ID: 36662337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
    PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease in nonalcoholic fatty liver disease at primary healthcare centers in Korea.
    Nah EH; Shin SK; Cho S; Park H; Kim S; Kwon E; Cho HI
    PLoS One; 2022; 17(12):e0279367. PubMed ID: 36538567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease.
    Luo K; Bian J; Wang Q; Wang J; Chen F; Li H; Jin D
    Turk J Gastroenterol; 2019 Jul; 30(7):611-615. PubMed ID: 31290748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
    Chinnadurai R; Ritchie J; Green D; Kalra PA
    Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrence of HBV infection and non-alcoholic fatty liver disease is associated with higher prevalence of chronic kidney disease.
    Lin S; Wang M; Liu Y; Huang J; Wu Y; Zhu Y; Wang X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101483. PubMed ID: 32646847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: a propensity-matched cohort study.
    Park H; Dawwas GK; Liu X; Nguyen MH
    J Intern Med; 2019 Dec; 286(6):711-722. PubMed ID: 31359543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD).
    Roderburg C; Krieg S; Krieg A; Demir M; Luedde T; Kostev K; Loosen SH
    Eur J Med Res; 2023 Apr; 28(1):153. PubMed ID: 37062837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994.
    Sirota JC; McFann K; Targher G; Chonchol M; Jalal DI
    Am J Nephrol; 2012; 36(5):466-71. PubMed ID: 23128368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels.
    Ma C; Liu Y; He S; Zeng J; Li P; Ma C; Ping F; Zhang H; Xu L; Li W; Li Y
    Front Endocrinol (Lausanne); 2020; 11():600472. PubMed ID: 33329401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.
    Zuo G; Xuan L; Xin Z; Xu Y; Lu J; Chen Y; Dai M; Zhang D; Wang W; Li M; Bi Y; Ning G; Xu M
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3957-e3968. PubMed ID: 34125886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography.
    Behairy MA; Sherief AF; Hussein HA
    Int Urol Nephrol; 2021 Dec; 53(12):2593-2601. PubMed ID: 33675475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study.
    Zhang Q; Ma X; Xing J; Shi H; Yang R; Jiao Y; Chen S; Wu S; Zhang S; Sun X
    Front Endocrinol (Lausanne); 2021; 12():657856. PubMed ID: 34054728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
    Zhang M; Lin S; Wang MF; Huang JF; Liu SY; Wu SM; Zhang HY; Wu ZM; Liu WY; Zhang DC; Hao CM; Zhu YY; Zheng MH; Wang XZ
    BMC Gastroenterol; 2020 May; 20(1):139. PubMed ID: 32375660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population.
    Cui Y; Liu J; Shi H; Hu W; Song L; Zhao Q
    J Diabetes Complications; 2021 May; 35(5):107874. PubMed ID: 33640265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes.
    Li Y; Zhu S; Li B; Shao X; Liu X; Liu A; Wu B; Zhang Y; Wang H; Wang X; Deng K; Liu Q; Huang M; Liu H; Holthöfer H; Zou H
    Int Urol Nephrol; 2014 Sep; 46(9):1785-91. PubMed ID: 25099524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of chronic kidney disease in patients with non-alcoholic fatty liver disease: A cohort study.
    Sinn DH; Kang D; Jang HR; Gu S; Cho SJ; Paik SW; Ryu S; Chang Y; Lazo M; Guallar E; Cho J; Gwak GY
    J Hepatol; 2017 Dec; 67(6):1274-1280. PubMed ID: 28870674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.